![Page 1: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/1.jpg)
Appropriate Medication Usage After TBI: Cognition, Behavior
and Beyond
David X. Cifu, M.D.The Herman J. Flax, M.D. Professor and Chairman
Department of Physical Medicine and Rehabilitation
Virginia Commonwealth University/Medical College of Virginia
![Page 2: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/2.jpg)
Guidelines for Medication Usage After TBI
Define the problem as objectively and specifically as possible.
Use medicines that have some proven efficacy; don’t just use “something” (e.g. Neurontin).
Develop clear cut goals and metrics to assist in determining when to stop treatment.
Begin low but get to a therapeutic dosing before abandoning usage.
Be alert to side effects and undesired effects.
![Page 3: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/3.jpg)
Alterations in Cognition and Behavior After TBI
Hypoarousal Hypoattention Memory Deficits Depression Delirium Agitation
![Page 4: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/4.jpg)
Factors Affecting Cognitive and Behavioral Function After TBI
Effects of the TBI Medical Instability
– Infection
– Metabolic Disturbances
– Hormonal/NeuroEndocrine Disturbances
– Hypoxia
– Sleep-Wake Disturbances
– Pain
– Seizures
![Page 5: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/5.jpg)
Factors Affecting Cognitive and Behavioral Function After TBI Medications
– Cognitive-Impairing Medications• Central Acting Antihypertensives (Clonidine)
• Central Acting Antispasmodics (Tizanidine)
• GI Agents (H2 Blockers, Reglan)
• Pain Medications (Narcotics, ? NSAID’s)
• Sedatives (Benzodiazepines, Sleep Aids)
• Anticonvulsants (Phenytoin, Carbamazepine, Phenobarbital)
![Page 6: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/6.jpg)
Factors Affecting Cognitive and Behavioral Function After TBI
– Cognitive-Improving Medications• Stimulants [Methylphenidate, Dextramphetamine]
• Amantadine [Symmetrel]
• Bromocriptine [Parlodel]
• Selective Serotoninergic Re-Uptake Inhibitors [Prozac, Zoloft, Paxil,Celexa]
• Combination Antidepressants [Wellbutrin]
• ? Levodopa-Carbidopa [Sinemet]
• ? Anti-Alzheimer's Agents [Aricept, Exelon]
![Page 7: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/7.jpg)
Coma Intervention
Directed Multisensory Stimulation (DMS) demonstrated superior (increased responsiveness, improved RLAS, improved GCS) versus Non-Directed Stimulation (NDS) in RLAS II patients
Hall:Brain Injury 1992:6:435-45
![Page 8: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/8.jpg)
Coma Intervention
Comatose receiving greater therapy intensity (by 60%) demonstrated a 31% decrease in length of stay.
Blackerby:Brain Injury 1989;4:167-73
![Page 9: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/9.jpg)
Cognitive Interventions: Hypoarousal
No reliable data to support the efficacy of pharmacologic intervention in the comatose (RLAS I) or vegetative (RLAS II) patient. All you get is a very “alert”-looking comatose or vegetative patient.
Small trials do support use of neurostimulants (Amantadine 150 mg bid) in “emerging” patients (RLAS III).
Kaelin: Arch Phys Med Rehabil 1996;77:6-9
![Page 10: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/10.jpg)
Cognitive Interventions: Hypoattention
Neurostimulants have been demonstrated to improve attention (and +/- function) in responsive patients (RLAS IV-VIII) .
Methylphenidate has the most clinically demonstrated efficacy for individuals who have progressed out of coma.
Dosing 5-30 mg q 7am and 12 pm.Kaelin: Arch Phys Med Rehabil 1996;77:6-
9
![Page 11: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/11.jpg)
Methylphenidate (Ritalin)
Modes of Action
– Release of Dopamine from reserpine sensitive presynaptic pool
Braestrup: J Pharm. Pharmacol. 1977, 29: 463 - 470.
– Inhibition of Dopamine uptake Ferris,Tang: J of Pharmacol. Exp. Ther. 1979, 210: 422 - 428.
– Inhibition of Monoamine Oxidase Szporny, Gorog: Biochem. Pharmacol. 1961, 8: 263 - 268.
![Page 12: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/12.jpg)
Methylphenidate (Ritalin)
Pharmacokinetics– Peak serum levels are reached within 2 hours
(Half life = 2-4 hrs)– Both a wide inter-individual and intra-
individual variability in serum concentrations exist
– MPH levels are not different in responders and non-responders
Gualtieri, CT, et al. J of Amer Acad of Child Psych 1982, 21(1): 19-26.
![Page 13: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/13.jpg)
Selective Serotonin Re-Uptake Inhibitors (SSRI’s)
Prozac, Zoloft, Paxil, Celexa Inhibit CNS reuptake of Serotonin Activating antidepressants, however
somnolence present w/ Paxil at doses >20 mg/day
Increase dosage q 4-6 weeks If treating depression, need to commit to 12
month course (or increase recurrence)
![Page 14: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/14.jpg)
Bromocriptine (Parlodel) Dopamine receptor agonist Adjunctive treatment for Parkinson’s disease Suggested for low level patients, however limited
proven efficacy Dosage: 2.5-15 mg/day in 2 doses Increase dosage weekly High incidence of N/V and Headaches with
increasing dosages.
![Page 15: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/15.jpg)
Amantadine (Symmetrel) Potentiates Dopamine (mechanism unclear) Adjunctive treatment for Parkinson’s disease
(tremor) Dosage: 100-400mg/day in bid dosing
(elevated seizure risk above 300 mg/day) Increase dosage weekly Hallucinations dose limiting side effect. Probable efficacy in RLAS III patients.
![Page 16: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/16.jpg)
Other Antidepressants [Effexor, Wellbutrin]
Effexor and Wellbutrin inhibit Serotonin, NE, and Dopamine reuptake = Activating agents
Effexor Dosage: 75-225 mg/day in 2-3 doses (Occasional HTN side effects)
Wellbutrin Dosage: 200-450 mg/day in 3 doses (May have worsening effects on agitation)
![Page 17: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/17.jpg)
Levodopa-Carbidopa [Sinemet] Increases cerebral dopamine Suggested for low level patients, however
limited proven efficacy Side effects can include dyskinesias and
cognitive changes Dosage: 400-1600 mg Levodopa/day in 2-3
doses (tablets contain either 100 or 200 mg Levodopa)
![Page 18: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/18.jpg)
Anti-Alzheimer's Agents [Aricept, Exelon]
Reversible cholinesterase inhibitors = increases cerebral acetylcholine
Effective in improving memory in individuals with Alzheimer’s disease
Limited research suggests efficacy in TBI patients
Extremely expensive, occasional GI side effects
![Page 19: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/19.jpg)
Treatment Algorithm: Hypoarousal/Hypoattention
Day 1– Define pathology -> CT/MRI, Mechanism of Injury, Secondary BI– Assess function: DRS, FIM, RLAS (limited efficacy in RLAS I-III)– Assess medical status -> Infections, Oxygenation, Metabolics, Fluid
Status, Seizures– Remove medications -> H2 blockers, narcotics, central acting anti-
HTN/GI, Benzodiazepines, Sleepers
Day 1-4– Stabilize/Improve medical status– Assess/Improve sleep-wake cycle: Trazadone, Ambien– Assess behavior: ABS, Therapy attendance/participation, Attention
to Task
![Page 20: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/20.jpg)
Treatment Algorithm: Hypoarousal/Hypoattention
Day 5-10– Initiate Methylphenidate 5 mg q 7 am and 12 pm, increase 5-10
mg/day to 60 mg maximum
– Monitor behavior and sleep-wake cycle
Day 10-20– If Methylphenidate effective, continue at lowest effective dose for
2-3 weeks, then wean off in 2-4 days
– If Methylphenidate ineffective by 30 mg/day, then initiate wean and begin new agent.
– Recommend: SSRI’s may be appropriate if mild but limited response to Ritalin ( if depression is suspected, then Ritalin only effective 4-6 weeks and will need SSRA for 3 months minimum).
![Page 21: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/21.jpg)
Cognitive Interventions: Agitation
Agitation occurs in >50% of all TBI patients (RLAS IV), however delirium, seizures, pain, hypoxia can also manifest with agitation.
True TBI agitation should be treated with environmental and behavioral interventions.
Pharmacologic treatment should only be implemented in specific behaviors are identified and goals established.
Agitation is defined as an Agitated Behavior Scale score > 21
![Page 22: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/22.jpg)
Cognitive Interventions: Agitation
Etiologies– Environmental– Pain– Seizure activity– Delirium (meds, hypoxia, metabolic)– Inadequate sleep/wake hygiene
… or TBI-related confusion
![Page 23: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/23.jpg)
Cognitive Interventions: Agitation
Treatment– Assess for correctable
etiology• Sleep/Wake Charting• Medical Management
– Behavioral• establish desired
behavior• positive reinforcement• shaping• structured therapy
– Agitated Behavior Scale
• Assess pattern of agitation
• Documentation• Evaluate effectiveness of
intervention
– Physical Restraint– Pharmacologic
• ABS > 28
![Page 24: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/24.jpg)
Agitation: Medications
Day 1-3 Use prn for ABS >28– Ativan– Risperidone
Day 4+– Schedule agents if persistent ABS > 28
• Aggression - Beta-Blockers (Propranolol)• Restlessness - AED’s (Tegretol, VPA)• Emotional lability - TCA’s (Nortriptyline)
– Wean agent when ABS <21 for 3 days.Cifu: J NeuroRehabil 1995;5:245-254
![Page 25: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/25.jpg)
Post-Traumatic Seizures: Background
TBI-related seizures account for 20% of symptomatic epilepsy. Hauser: Epilepsia 1991:32;429-45
PTS accounts for 5% of all cases of epilepsy.
Hauser: Epilepsia 1991:32;429-45 Late PTS is present in 4-7% all TBI, nearly 20% rehab
TBI, and 35-50% penetrating TBI patients. Yablon: Arch PM&R 1993:74;983-1001
EEG has no predictive value for PTS. Yablon: Arch PM&R 1993:74;983-1001
![Page 26: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/26.jpg)
Prophylaxis for PTS
73% reduction in early PTS and 50% reduction in 1 year PTS in individuals given phenytoin for 1 week post-TBI.
No proven benefits to giving prophylaxis >7 days post-TBI. Temkin:N Engl J Med 1990:323;497-502
No benefit to use of up to 1 month VPA.Temkin: J NeuroSurg 1999:91;593-600
AANS and AAPM&R recommend 7 days of either PTH or CBZ post-TBI.
![Page 27: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/27.jpg)
Prophylaxis for PTS
Do not treat seizure in first 24 hours post-TBI longer than initial 7 days, unless status epilepticus.
Seizures in the first week should be treated (1 year) unless there is a non-TBI cause evident (infection, hypoxia, metabolic, hydrocephalus).
Seizures after 1 week must be treated for at least 1 year.
![Page 28: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/28.jpg)
GI Ulcer Prophylaxis
Use of H2-Blockers has been demonstrated to decrease ICU-related stress ulceration of the GI tract in specific patient populations (e.g., burns).
No specific information in patients with TBI, with or w/o PEG/J tubes.
![Page 29: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/29.jpg)
GI Ulcer Prophylaxis
Newer H2-Blockers, while expensive, have limited CNS effects.
High risk patients (h/o PUD, h/o GERD, comatose, > 65 years old) are appropriate for prophylaxis while in ICU.
No clear indication for all TBI patients in ICU.
![Page 30: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/30.jpg)
Spasticity Management
Treatment should be initiated if the spasticity is limiting function, ROM, or is causing pain.
Potential side effects of treatment must be weighed against potential benefits.
![Page 31: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/31.jpg)
Spasticity Management:Third Line
Systemic medications are effective, but often have systemic side effects:– Hepatotoxicity (Baclofen, Dantrium)– Generalized weakness (Dantrium)– Lethargy (Zanaflex, Baclofen, Valium)– Hypotension (Zanaflex)– Addiction (Valium)
![Page 32: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/32.jpg)
Spasticity Management:Third Line
Dantrolene Sodium (Dantrium)– Acts peripheral by blocking release of Ca++ from the t-
tubules of the sarcoplasmic reticulum.
– Hepatotoxicity is not uncommon.
– May cause generalized weakness.
– No central effects.
– Most often used in Brain Injury and CVA.
– Start 25 mg qid -> Max 100 mg qid.
![Page 33: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/33.jpg)
Spasticity Management:Third Line
Tizanidine (Zanaflex)– Central acting alpha-blocker.– Often causes hypotension.– May cause lethargy.– very gradual dose increase.– Most often used in SCI.– Start 1 mg tid -> Max 8 mg tid.
![Page 34: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/34.jpg)
Spasticity Management:Fourth Line
Phenol (1-10% Aqueous Solution)– Direct neurocidal agent, effect lasts for 3-6
months (until nerve regenerates). Works immediately.
– Eliminates spasticity in specific nerve distribution or muscle.
– Nerve/muscle motor point (where nerve innervates) must be isolated electrically.
– Inexpensive.
![Page 35: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/35.jpg)
Spasticity Management:Fourth Line
Botulinum Toxin (Botox, NeuroTox)– Neurotoxin that prevents the release of
acetylcholine (Ach) from presynaptic vacuoles at the neuromuscular junction.
– Produces paralysis of the muscle for 2-4 months.
– Maximal effects take 2 weeks.– Expensive.
![Page 36: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/36.jpg)
Spasticity Management:Fourth Line
Focal blockade needs to be combined with a structured stretching/bracing program.
Focal blockade often reveals underlying connective tissue contractures.– If they are “soft”, they can be improved with
stretching.– If they are hard, surgical intervention is
indicated.
![Page 37: Appropriate Medication Usage After TBI: Cognition, Behavior and Beyond David X. Cifu, M.D. The Herman J. Flax, M.D. Professor and Chairman Department of](https://reader035.vdocuments.net/reader035/viewer/2022062417/551a8013550346b52d8b563a/html5/thumbnails/37.jpg)
Guidelines for Medication Usage After TBI
Define the problem as objectively and specifically as possible.
Use medicines that have some proven efficacy; don’t just use “something” (e.g. Neurontin).
Develop clear cut goals and metrics to assist in determining when to stop treatment.
Begin low but get to a therapeutic dosing before abandoning usage.
Be alert to side effects and undesired effects.